Cargando…

The reproducibility of late gadolinium enhancement cardiovascular magnetic resonance imaging of post-ablation atrial scar: a cross-over study

BACKGROUND: Cardiovascular magnetic resonance (CMR) imaging has been used to visualise post-ablation atrial scar (PAAS), generally employing a three-dimensional (3D) late gadolinium enhancement (LGE) technique. However the reproducibility of PAAS imaging has not been determined. This cross-over stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Chubb, Henry, Karim, Rashed, Roujol, Sébastien, Nuñez-Garcia, Marta, Williams, Steven E., Whitaker, John, Harrison, James, Butakoff, Constantine, Camara, Oscar, Chiribiri, Amedeo, Schaeffter, Tobias, Wright, Matthew, O’Neill, Mark, Razavi, Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5858144/
https://www.ncbi.nlm.nih.gov/pubmed/29554919
http://dx.doi.org/10.1186/s12968-018-0438-y
_version_ 1783307599219785728
author Chubb, Henry
Karim, Rashed
Roujol, Sébastien
Nuñez-Garcia, Marta
Williams, Steven E.
Whitaker, John
Harrison, James
Butakoff, Constantine
Camara, Oscar
Chiribiri, Amedeo
Schaeffter, Tobias
Wright, Matthew
O’Neill, Mark
Razavi, Reza
author_facet Chubb, Henry
Karim, Rashed
Roujol, Sébastien
Nuñez-Garcia, Marta
Williams, Steven E.
Whitaker, John
Harrison, James
Butakoff, Constantine
Camara, Oscar
Chiribiri, Amedeo
Schaeffter, Tobias
Wright, Matthew
O’Neill, Mark
Razavi, Reza
author_sort Chubb, Henry
collection PubMed
description BACKGROUND: Cardiovascular magnetic resonance (CMR) imaging has been used to visualise post-ablation atrial scar (PAAS), generally employing a three-dimensional (3D) late gadolinium enhancement (LGE) technique. However the reproducibility of PAAS imaging has not been determined. This cross-over study is the first to investigate the reproducibility of the technique, crucial for both future research design and clinical implementation. METHODS: Forty subjects undergoing first time ablation for atrial fibrillation (AF) had detailed CMR assessment of PAAS. Following baseline pre-ablation scan, two scans (separated by 48 h) were performed at three months post-ablation. Each scan session included 3D LGE acquisition at 10, 20 and 30 min post administration of gadolinium-based contrast agent (GBCA). Subjects were allocated at second scan post-ablation to identical imaging parameters (‘Repro’, n = 10), 3 T scanner (‘3 T’, n = 10), half-slice thickness (‘Half-slice’, n = 10) or half GBCA dose (‘Half-gad’, n = 10). PAAS was compared to baseline scar and then reproducibility was assessed for two measures of thresholded scar (% left atrial (LA) occupied by PAAS (%LA PAAS) and Pulmonary Vein Encirclement (PVE)), and then four measures of non-thresholded scar (point-by-point assessment of PAAS, four normalisation methods). Thresholded measures of PAAS were evaluated against procedural outcome (AF recurrence). RESULTS: A total of 271 3D acquisitions (out of maximum 280, 96.7%) were acquired. At 20 and 30 min, inter-scan reproducibility was good to excellent (coefficient of variation at 20 min and 30 min: %LA PAAS 0.41 and 0.20; PVE 0.13 and 0.04 respectively for ‘Repro’ group). Changes in imaging parameters, especially reduced GBCA dose, reduced inter-scan reproducibility, but for most measures remained good to excellent (ICC for %LA PAAS 0.454–0.825, PVE 0.618–0.809 at 30 min). For non-thresholded scar, highest reproducibility was observed using blood pool z-score normalisation technique: inter-scan ICC 0.759 (absolute agreement, ‘Repro’ group). There was no significant relationship between indices of PAAS and AF recurrence. CONCLUSION: PAAS imaging is a reproducible finding. Imaging should be performed at least 20 min post-GBCA injection, and a blood pool z-score should be considered for normalisation of signal intensities. The clinical implications of these findings remain to be established in the absence of a simple correlation with arrhythmia outcome. TRIAL REGISTRATION: United Kingdom National Research Ethics Service 08/H0802/68 – 30th September 2008. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12968-018-0438-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5858144
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58581442018-03-20 The reproducibility of late gadolinium enhancement cardiovascular magnetic resonance imaging of post-ablation atrial scar: a cross-over study Chubb, Henry Karim, Rashed Roujol, Sébastien Nuñez-Garcia, Marta Williams, Steven E. Whitaker, John Harrison, James Butakoff, Constantine Camara, Oscar Chiribiri, Amedeo Schaeffter, Tobias Wright, Matthew O’Neill, Mark Razavi, Reza J Cardiovasc Magn Reson Research BACKGROUND: Cardiovascular magnetic resonance (CMR) imaging has been used to visualise post-ablation atrial scar (PAAS), generally employing a three-dimensional (3D) late gadolinium enhancement (LGE) technique. However the reproducibility of PAAS imaging has not been determined. This cross-over study is the first to investigate the reproducibility of the technique, crucial for both future research design and clinical implementation. METHODS: Forty subjects undergoing first time ablation for atrial fibrillation (AF) had detailed CMR assessment of PAAS. Following baseline pre-ablation scan, two scans (separated by 48 h) were performed at three months post-ablation. Each scan session included 3D LGE acquisition at 10, 20 and 30 min post administration of gadolinium-based contrast agent (GBCA). Subjects were allocated at second scan post-ablation to identical imaging parameters (‘Repro’, n = 10), 3 T scanner (‘3 T’, n = 10), half-slice thickness (‘Half-slice’, n = 10) or half GBCA dose (‘Half-gad’, n = 10). PAAS was compared to baseline scar and then reproducibility was assessed for two measures of thresholded scar (% left atrial (LA) occupied by PAAS (%LA PAAS) and Pulmonary Vein Encirclement (PVE)), and then four measures of non-thresholded scar (point-by-point assessment of PAAS, four normalisation methods). Thresholded measures of PAAS were evaluated against procedural outcome (AF recurrence). RESULTS: A total of 271 3D acquisitions (out of maximum 280, 96.7%) were acquired. At 20 and 30 min, inter-scan reproducibility was good to excellent (coefficient of variation at 20 min and 30 min: %LA PAAS 0.41 and 0.20; PVE 0.13 and 0.04 respectively for ‘Repro’ group). Changes in imaging parameters, especially reduced GBCA dose, reduced inter-scan reproducibility, but for most measures remained good to excellent (ICC for %LA PAAS 0.454–0.825, PVE 0.618–0.809 at 30 min). For non-thresholded scar, highest reproducibility was observed using blood pool z-score normalisation technique: inter-scan ICC 0.759 (absolute agreement, ‘Repro’ group). There was no significant relationship between indices of PAAS and AF recurrence. CONCLUSION: PAAS imaging is a reproducible finding. Imaging should be performed at least 20 min post-GBCA injection, and a blood pool z-score should be considered for normalisation of signal intensities. The clinical implications of these findings remain to be established in the absence of a simple correlation with arrhythmia outcome. TRIAL REGISTRATION: United Kingdom National Research Ethics Service 08/H0802/68 – 30th September 2008. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12968-018-0438-y) contains supplementary material, which is available to authorized users. BioMed Central 2018-03-19 /pmc/articles/PMC5858144/ /pubmed/29554919 http://dx.doi.org/10.1186/s12968-018-0438-y Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Chubb, Henry
Karim, Rashed
Roujol, Sébastien
Nuñez-Garcia, Marta
Williams, Steven E.
Whitaker, John
Harrison, James
Butakoff, Constantine
Camara, Oscar
Chiribiri, Amedeo
Schaeffter, Tobias
Wright, Matthew
O’Neill, Mark
Razavi, Reza
The reproducibility of late gadolinium enhancement cardiovascular magnetic resonance imaging of post-ablation atrial scar: a cross-over study
title The reproducibility of late gadolinium enhancement cardiovascular magnetic resonance imaging of post-ablation atrial scar: a cross-over study
title_full The reproducibility of late gadolinium enhancement cardiovascular magnetic resonance imaging of post-ablation atrial scar: a cross-over study
title_fullStr The reproducibility of late gadolinium enhancement cardiovascular magnetic resonance imaging of post-ablation atrial scar: a cross-over study
title_full_unstemmed The reproducibility of late gadolinium enhancement cardiovascular magnetic resonance imaging of post-ablation atrial scar: a cross-over study
title_short The reproducibility of late gadolinium enhancement cardiovascular magnetic resonance imaging of post-ablation atrial scar: a cross-over study
title_sort reproducibility of late gadolinium enhancement cardiovascular magnetic resonance imaging of post-ablation atrial scar: a cross-over study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5858144/
https://www.ncbi.nlm.nih.gov/pubmed/29554919
http://dx.doi.org/10.1186/s12968-018-0438-y
work_keys_str_mv AT chubbhenry thereproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy
AT karimrashed thereproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy
AT roujolsebastien thereproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy
AT nunezgarciamarta thereproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy
AT williamsstevene thereproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy
AT whitakerjohn thereproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy
AT harrisonjames thereproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy
AT butakoffconstantine thereproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy
AT camaraoscar thereproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy
AT chiribiriamedeo thereproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy
AT schaefftertobias thereproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy
AT wrightmatthew thereproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy
AT oneillmark thereproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy
AT razavireza thereproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy
AT chubbhenry reproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy
AT karimrashed reproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy
AT roujolsebastien reproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy
AT nunezgarciamarta reproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy
AT williamsstevene reproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy
AT whitakerjohn reproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy
AT harrisonjames reproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy
AT butakoffconstantine reproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy
AT camaraoscar reproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy
AT chiribiriamedeo reproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy
AT schaefftertobias reproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy
AT wrightmatthew reproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy
AT oneillmark reproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy
AT razavireza reproducibilityoflategadoliniumenhancementcardiovascularmagneticresonanceimagingofpostablationatrialscaracrossoverstudy